Mood Disorders

Latest News

Characterizing the Effect of CYP2C19/CYP2D6 Genotype on Plasma Drug Exposure to Antidepressant, Antipsychotic Medications

By

Emily Pond

The researchers of this study sought to quantify the difference in antipsychotic and antidepressant exposure among patients with genetically associated CYP2C19 and CYP2D6 poor (PM), intermediate (IM), and normal (NM) metabolizers.

Receipt of Disability Services Elevated in Individuals With Mood Disorders

By

Rose Reeb

Investigators looked into the risks of receiving disability services after a first diagnosis of mood or common mental disorder.

Complimentary, Alternative, Integrative Medicine Improves Outcomes in Patients With Mood Disorders

By

Psychiatry Advisor Contributing Writer

Implementation of complimentary, alternative, and integrative medicine can help improve patient symptoms in scenarios where conservative treatments have failed.

Associations Found Between Parents, Children, and Certain Mood Disorders

By

Heather R. Johnson

There have been few studies that have examined the specificity of mood disorder subtypes among the children of parents with both major subtypes of mood disorders and controls based on prospective tracking across the transition from childhood to adulthood.

Diabetes, CVD, and Mood Disorders Prevalent in Patients With Palmoplantar Plaque Psoriasis

By

Brandon May

The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.

Staying on Antidepressants During Pregnancy Increases Risk of Obstetric Complications, Postpartum Psychiatric Disorders

By

Brandon May

Women who stopped antidepressant treatment during pregnancy and resumed in the following weeks had a rebound effect of increased prescription of benzodiazepines and anxiolytics.

Child Developmental Vulnerability Up With Maternal Depression

Children exposed to maternal depression have an increased risk for developmental vulnerability at school entry, with stronger associations for exposure to maternal depression before age 1 year and between ages 4 and 5 years.

Mood Disorders Affect Ability to Adapt to Changes Due to COVID-19

By

Jessica Nye, PhD

Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.

Spravato Approved for MDD With Acute Suicidal Ideation or Behavior

By

Brian Park, PharmD

The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.

Botox Injections May Ease Depression

Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.